Marc Tracy
By Marc Tracy
-
Books Author Blog: Semitic Squads
Earlier this week, Marc Tracy challenged Jewish sports fans to a little quiz and wrote about Jews in sports and Hollywood. His blog posts are featured on The Arty Semite courtesy of the Jewish Book Council and My Jewish Learning’s Author Blog Series. For more information on the series, please visit: Each of our 50…
-
Books Do You Know These Jewish Jocks?
On Tuesday, Marc Tracy wrote about Jews in sports and Hollywood. His blog posts are featured on The Arty Semite courtesy of the Jewish Book Council and My Jewish Learning’s Author Blog Series. For more information on the series, please visit: In the movie Airplane, a passenger asks for some “light” reading and is offered…
-
The Schmooze Sports Is Like Hollywood: They’re Both Jewish!
Marc Tracy is the co-editor of the new book “Jewish Jocks: An Unorthodox Hall of Fame.” His blog posts are featured on The Arty Semite courtesy of the Jewish Book Council and My Jewish Learning’s Author Blog Series. For more information on the series, please visit: In “Operation Shylock,” Philip Roth wrote a passage that,…
-
News Blogging Through A Tough Battle
Three young girls with juvenile Tay-Sachs ? Dakota Bihn, Alexis Markowich, and Jashaia Small ? are currently receiving umbilical-cord-blood therapy at Duke University Medical Center. The girls are under the care of Dr. Joanne Kurtzberg, who, as the Forward reported last year, has already performed cord-blood therapy on children with Krabbé disease. Thanks to the…
-
News Tay-Sachs Drug Trial Yields ‘Neutral’ Results
Two clinical studies for the treatment of late-onset Tay-Sachs with Zavesca, a drug used to treat Gaucher disease, produced neutral results — “a scientific way of saying that it didn’t work,” said Kim Crawford, director of member services for the National Tay-Sachs & Allied Diseases Association. According to Crawford, Actelion, which produces Zavesca, will not…
-
News Researchers Into Lysosomal Storage Find Common Ground
Earlier this year, the Lysosomal Storage Disease Research Consortium awarded its first seven grants, which together total more than $200,000, to scientists conducting research into ameliorating the effects of lysosomal-storage diseases on the central nervous system. There are more than 40 of these diseases, called LSDs, including Tay-Sachs, Gaucher disease, mucopolysaccharidosis (MPS) and Niemann-Pick disease….
-
Culture High School Seniors Open Interfaith Dialogue
During the last school year, seniors at the Abraham Joshua Heschel High School, on Manhattan’s Upper West Side, met regularly with their counterparts at Al-Iman, an Islamic day school in Jamaica, Queens. Brought together by the Unity Program of Abraham’s Vision, a nonprofit organization dedicated to promoting dialogue between American Jews and Muslims, these students…
-
Israel News Major League Baseball And JCCs Join Forces
In late June, the JCC Association of North America and Major League Baseball announced grants to sponsor the after-school Rookie League Pitching Machine Program at 10 JCCs around the country. The league is geared toward players 12 and younger who are making the transition from hitting the ball off a tee to live-pitch baseball. In…
Explore
Most Popular
- 1
Fast Forward Tucker Carlson calls for stripping citizenship from Americans who served in the Israeli army
- 2
Film & TV The new ‘Superman’ is being called anti-Israel, but does that make it pro-Palestine?
- 3
News Meet the Jews who helped elect Zohran Mamdani
- 4
Opinion This German word explains Trump’s authoritarian impulses — and Hitler’s rise to power
In Case You Missed It
-
Fast Forward Mike Huckabee denounces killing of Palestinian-American in the West Bank as ‘terrorist act’
-
Fast Forward Andrew Cuomo lists several Jewish endorsements on his website. But do they still apply?
-
Fast Forward Antisemitic memes fail to disqualify Elon Musk’s ‘MechaHitler’ bot from Department of Defense contract
-
Fast Forward ‘The wrong message’: Jewish groups slam Brad Lander for divesting from Israel
-
Shop the Forward Store
100% of profits support our journalism
